PPT-Medical Cannabis Education

US Federal Patent httppatftusptogovnetacginphParserSect1PTO1ampSect2HITOFFampdPALLampp1ampu2Fnetahtml2FPTO2Fsrchnumhtmampr1ampfGampl50amps16630507PNampOSPN6630507ampRSPN6630507. Professor Les Iversen. University of Oxford. Female Cannabis Flower. William O’Shaughnessy – a Victorian Genius. 1832. – (age 22) . idea for fluid/electrolyte replacement in cholera. 1833. -Joined East India Company in Calcutta as physician, surgeon, professor of Chemistry and scientist –validated folk use of cannabis. Talking to your doctor, Safety and Update on Clinical Trials. Lubov. . Romantseva. , MD. Child Neurology and Epilepsy. Rush University Medical Center. Nov 12, 2016. Disclosures. I have no financial interest in any pharmaceutical company mentioned in this presentation. 11/. . 12. . /. . 16. Bob Morgan. Illinois Medical Cannabis Pilot Program Act. 2. Four . year pilot program beginning January 1, 2014 entitled the . “Illinois Compassionate Use of Medical . Cannabis Pilot Program . September 2016. Implementation Timeline. Office of Compassionate Use Established. : July 1, 2014. Florida Administrative Code Chapter 64-4 Promulgated, Final Rule Upheld: . May 28, 2015. Dispensing Organization Applications Accepted: . Presented by: Candice Beathard, PhD. December 15, 2015 . Background. 23 States and D.C. have enacted medical cannabis programs. 1. . 1. Marijuana Policy Project, 2015. . Background. State programs specify list of qualifying conditions. drug control . system and its effects on science. Tom Blickman– TNI. tblick@tni.org. The Rise and Decline of Cannabis Prohibition. The . History of Cannabis in the UN Drug Control System and Options For Reform. he . Report of the Task Force on Cannabis Legalization and Regulation. For. Emerging Practices and Legal Context for Prescription Drugs and Marijuana in VAW Shelters. Susan Boyd, PhD, University of Victoria. Gregg VandeKieft, MD, MA. WSHPCO “Expanding dimensions in hospice & palliative care”. Chelan, . wa. October 10, 2017. Disclosure. Dr. VandeKieft does not have any conflicts of interest to disclose. He will discuss medical applications of cannabis, but will not discuss off-label use of medications.. What are the effects of the current cannabis policy? . How is cannabis policy changing in other states?. What technical elements need to be addressed? . What goals should Minnesota have for legalizing adult-use cannabis?. Qualifying medical conditions are typically defined on a state level and are required to permit the order of medical cannabis.. Objectives: . To identify and map the most recently (2016-2019) published clinical and scientific literature across approved conditions for medical cannabis, and; . 2021 ANNUAL REPORT. Myles J. Willingham. Division Chief of Medical Cannabis Patient Program. Table of Contents. . Objectives. Explain the history of CBD and Hemp. Discuss cannabis-based approved medications in the US. Explore the marketing and efficacy of CBD. Discuss the legality of the use of CBD in the nation. Prohibition. Common Questions. Violations and Sanctions. Legalization . History. Cannabinoids have been on the WADA Prohibited List since 2004. Prohibited List inclusion criteria:. The substance must meet two of the following:. world. Tania Ramírez. Map of countries in which medicinal cannabis is available. Medicinal cannabis . regulated. Argentina, Australia, Brazil, Canada, Chile, Colombia, Croatia, Czech Republic, Finland, France, Germany, Greece, Israel, Italy,...